Evidence map›Paper›PMID 42278302›Full record

ArticleInternational journal of molecular sciences2026

Structure-Biomedical Activity Relationship of Tunable Ceria-Graphene Nanocomposites Leading to Divergent Cellular Responses.

Tudor-Mihai Magdaș, Ioana Bâldea, Constantin Bodolea, Andrei Mihai Bălan, Adrian Ștef, Lidia Mǎgeruşan, Gabriela Adriana Filip

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tudor-Mihai MagdașAnesthesia and Intensive Care Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, 8 Victor Babeş Street, 400012 Cluj-Napoca, Romania.ORCID 0000-0002-0774-020X
Ioana BâldeaDepartment of Physiology, Faculty of Medicine, University of Medicine and Pharmacy "Iuliu Hatieganu", 400347 Cluj-Napoca, Romania.ORCID 0000-0003-4046-7310
Constantin BodoleaAnesthesia and Intensive Care Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, 8 Victor Babeş Street, 400012 Cluj-Napoca, Romania.
Andrei Mihai BălanAnesthesia and Intensive Care Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, 8 Victor Babeş Street, 400012 Cluj-Napoca, Romania.
Adrian ȘtefAnesthesia and Intensive Care Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, 8 Victor Babeş Street, 400012 Cluj-Napoca, Romania.ORCID 0000-0001-5574-3969
Lidia MǎgeruşanNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Street, 400293 Cluj-Napoca, Romania.ORCID 0000-0002-7998-7754
Gabriela Adriana FilipNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Street, 400293 Cluj-Napoca, Romania.ORCID 0000-0002-7447-4925

Funding

Ministerul Cercetării și Inovării PN 23 24 03 01
6 · The paper itself

Abstract

Graphene-based nanomaterials (GBNs) have emerged as promising candidates for diverse biomedical applications, but their clinical translation has been hindered by inherent cytotoxicity. We synthesized three distinct cerium-containing graphene nanocomposites using a single-step, in situ electrochemical exfoliation process and investigated their structure-activity relationships in normal dermal fibroblasts (BJ) and hepatocarcinoma cells (HepG2). The properties of the resulting nanocomposites, including their morphology, cerium loading, and the surface redox state (Ce

Indexed as

CeriumGraphiteNanocompositesCell SurvivalFibroblastsHep G2 CellsHumansStructure-Activity RelationshipCeriumGraphitecerium-containing grapheneselectrochemical exfoliationgraphene-based nanomaterialshormesisselective cytotoxicitystructure-activity relationship

Identifiers

PMID42278302
PMCPMC13256777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.